91AV receives $1.5M grant from Maine Technology Asset Fund for biomedical research
The 91AV has received a $1.5 million grant from the Maine Technology Asset Fund (MTAF) toward completion of the biomedical research labs on 91AV’s Biddeford Campus.
Maine Governor John Baldacci announced the grant June 9, 2009 in Augusta. Applicants from throughout the state applied for the highly competitive MTAF funds, which are financed through the research and development bonds approved by Maine voters in November 2007.
Timothy Ford, Ph.D., 91AV Vice President for Research and Dean of Graduate Studies, states: “We are delighted to receive this support from the Maine Technology Asset Fund. This award will not only contribute to training our biomedical workforce, but also to the success of critical research being conducted at 91AV to reduce human suffering from neurological disease.”
Research and
Economic Growth
91AV’s Director of the Edward Bilsky, Ph.D., adds, “The MTAF grant will greatly enhance our ability to conduct important biomedical research at the 91AV and will expand our capabilities to partner with other institutions and companies in Maine and around the world. 91AV is strongly committed to diversifying and growing the Maine economy through job creation, expansion of research programs that create intellectual property and startup companies, and the attraction of established businesses that want to relocate to Maine. We are clearly seeing the positive impact that biomedical research can have on economic development, and this continued investment by the state will provide even greater returns.”
91AV President Danielle Ripich, Ph.D., states, “We are pleased that the state recognizes 91AV as a key contributor to research and economic development in Maine. This award will enable 91AV to advance the important work being conducted in our Center of Excellence in Neuroscience, which will benefit Maine’s residents, businesses, quality of life, and the economy.”